ST Segment Elevation Myocardial Infarction Clinical Trial
Official title:
Distal TransRAdial Access for Primary Percutaneous Coronary Intervention in STEMI Patients to Prevent Acute Radial Artery Occlusion
Randomized-controlled trial to comparison of early radial artery occlusion via distal vs proximal radial artery among ST segment elevation myocardial infarction patients for primary percutaneous coronary intervention.
Proximal radial artery (PRA) is recommend as the default approach for patients undergoing percutaneous coronary intervention (PCI) according 2018 ESC guidelines. However, radial artery occlusion(RAO) remains the frequent complication, precluding the future use of radial artery as access point for repeat coronary recanalization or as a conduit for coronary artery bypass surgery. More than 50% of patients with ST segment elevation myocardial infarction(STEMI) presents multiple vascular lesions, of which 50% require reprocessing non-culprit vessels. Therefore, the patency of radial artery is crucial for STEMI patients. Distal radial artery(DRA), located in anatomical snuffbox or the dorsum of the hand, was introduced as a promising alternative. Three recent RCTs have shown significant reductions of RAO after DRA compared with PRA. Nevertheless, all of them excluded the patients presenting with STEMI. Therefore, we conduct a prospective, single-center, open-label randomized clinical trial to assess the superiority of preventing RAO at 24h via DRA when compared PRA among STEMI patients for primary PCI. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02869906 -
Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Non Culprit Lesions in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
| Not yet recruiting |
NCT03895983 -
ST Segment Resolution After Primary Percutaneous Coronary Intervention.
|
||
| Not yet recruiting |
NCT03252665 -
Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI
|
Phase 4 | |
| Completed |
NCT02026219 -
Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT03247738 -
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
|
Phase 4 | |
| Recruiting |
NCT03561389 -
iFR-guided Revascularization in STEMI
|
||
| Completed |
NCT01538303 -
Microvascular Dysfunction in Acute Myocardial Infarction (AMI) and Its Relation to Outcome
|
||
| Recruiting |
NCT02979236 -
Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI
|
N/A | |
| Completed |
NCT05705089 -
Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
|
Phase 3 | |
| Completed |
NCT01897350 -
Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial
|
N/A | |
| Not yet recruiting |
NCT03753269 -
Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT03234348 -
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
|
Phase 3 | |
| Recruiting |
NCT03406832 -
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
|
N/A | |
| Recruiting |
NCT03406819 -
Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
|
N/A | |
| Recruiting |
NCT03508232 -
Doxycycline to Protect Heart Muscle After Heart Attacks
|
Phase 2 | |
| Recruiting |
NCT04220736 -
Early Prediction of QFR in STEMI-Pharmaco-invasice
|
||
| Completed |
NCT03780335 -
Early Prediction of QFR in STEMI-I
|
||
| Recruiting |
NCT03787745 -
Ischemic Postconditioning in STEMI Patients Treated With Primary PCI
|
N/A | |
| Recruiting |
NCT03621111 -
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction
|
N/A | |
| Recruiting |
NCT03764241 -
Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
|
Phase 3 |